Journavx is the first and only approved non-opioid oral painkiller and the first new class of pain medicine approved in more ...
The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class non-opioid analgesic to treat acute pain in adults. “Today’s approval is an ...